These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11353411)

  • 1. Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis.
    Yuki Y; Byun Y; Fujita M; Izutani W; Suzuki T; Udaka S; Fujihashi K; McGhee JR; Kiyono H
    Biotechnol Bioeng; 2001 Jul; 74(1):62-9. PubMed ID: 11353411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.
    Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S
    Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.
    Badawi AH; Siahaan TJ
    J Neuroimmunol; 2013 Oct; 263(1-2):20-7. PubMed ID: 23911075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB/c mice.
    Zhang B; Walsh MD; Nguyen KB; Hillyard NC; Cavanagh AC; McCombe PA; Morton H
    J Neurol Sci; 2003 Aug; 212(1-2):37-46. PubMed ID: 12809997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M; Johnson JM; Tuohy VK
    J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H
    J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Administration of Soluble Antigen Arrays Is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis.
    Kuehl C; Thati S; Sullivan B; Sestak J; Thompson M; Siahaan T; Berkland C
    J Pharm Sci; 2017 Nov; 106(11):3293-3302. PubMed ID: 28625726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
    McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
    J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice.
    Tuohy VK; Thomas DM
    J Neuroimmunol; 1995 Feb; 56(2):161-70. PubMed ID: 7532182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
    Sun JB; Rask C; Olsson T; Holmgren J; Czerkinsky C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7196-201. PubMed ID: 8692968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.
    Kennedy MK; Tan LJ; Dal Canto MC; Tuohy VK; Lu ZJ; Trotter JL; Miller SD
    J Immunol; 1990 Feb; 144(3):909-15. PubMed ID: 1688591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant.
    Goto N; Maeyama J; Yasuda Y; Isaka M; Matano K; Kozuka S; Taniguchi T; Miura Y; Ohkuma K; Tochikubo K
    Vaccine; 2000 Apr; 18(20):2164-71. PubMed ID: 10715532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.
    Croxford JL; Anger HA; Miller SD
    J Immunol; 2005 Jan; 174(2):907-17. PubMed ID: 15634913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
    Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
    J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
    Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
    Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannosylated PLP(139-151) induces peptide-specific tolerance to experimental autoimmune encephalomyelitis.
    Luca ME; Kel JM; van Rijs W; Wouter Drijfhout J; Koning F; Nagelkerken L
    J Neuroimmunol; 2005 Mar; 160(1-2):178-87. PubMed ID: 15710471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides.
    Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB
    Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.